in vitro News and Research

RSS

Lack of aftercare support for mothers of twins

New research by the Twins and Multiple Births Association (Tamba) has found that nearly 50 per cent of parents are left struggling unsupported after the birth.

4 Apr 2005

Adding growth factor to baby formula could reduce necrotizing enterocolitis

Could it be that the most widespread and devastating gastrointestinal disease affecting premature babies could be conquered simply by adding a common polypeptide, epidermal growth factor (EGF), to infant formula? And if so, exactly how does it work, and why?

3 Apr 2005

Discovery of missing enzyme for tuberculosis iron scavenging pathway

Scientists have discovered that a protein that was originally believed to be involved in tuberculosis antibiotic resistance is actually a "missing enzyme" from the biosynthetic pathway for an agent used by the bacteria to scavenge iron.

30 Mar 2005

REPLICor to disclose unique antiviral drug

REPLICor Inc., a privately owned biopharmaceutical company, is developing a broad spectrum antiviral drug called REP 9 which has the broadest spectrum of activity in vitro ever reported for a single chemical entity.

30 Mar 2005

Cells that might be able to suppres cat allergies

In a paper in this month's premier open-access medical journal PLoS Medicine, Mark Larche and colleagues from Imperial College London describe a subset of cells that might be able to suppress cells that cause cat allergy.

29 Mar 2005

New insights into Pemphigus

Pemphigus is a deadly skin blistering disease that occurs when patients' produce antibodies that attack proteins in their own cells – called autoantibodies.

28 Mar 2005

New weapon for asthmatics to combat winter asthma attacks

A British team from the University of Southampton, led by the world-acknowledged asthma experts, Professor Stephen Holgate and Professor Donna Davies, has identified a therapy used to treat multiple sclerosis (MS) as a potential novel treatment to reduce asthma attacks caused by the common cold virus.

23 Mar 2005

Degradable glass to help new bone growth

The University of Kent is collaborating with research teams from the University of Warwick, Imperial College London and University College London (UCL) to develop novel forms of degradable glass for a variety of medical applications, including new bone growth.

23 Mar 2005

Smart nanocarrier technology will cancer treatment

A ‘smart’ nanocarrier technology developed by a team of researchers at the Institute of Bioengineering and Nanotechnology (IBN) is set to vastly improve the way cancer patients are treated.

22 Mar 2005

Time for ethical reflection is before experimentation begins

The time for ethical reflection is before experimentation begins, especially in the case of potential new methods for creating human embryos for research, according to bioethicists from Wake Forest University Baptist Medical Center and the Mayo Clinic in the spring issue of Ethics & Medicine.

16 Mar 2005

Brewing up potential anti-cancer drugs from green tea

Drinking green tea has a protective effect against some forms of cancer but drinking large amounts can increase the risk of birth defects such as spina bifida – according to previous epidemiological studies.

15 Mar 2005

Association between prolonged residential radon exposure and lung cancer risk

Two University of Iowa researchers were part of a large multi-center study that provides compelling direct evidence of an association between prolonged residential radon exposure and lung cancer risk.

14 Mar 2005

Discovery may provide a new target to treat sepsis

Part of the immune system's pro-inflammatory response to bacterial invasion is to increase nitric oxide levels with an enzyme called inducible nitric oxide synthase.

14 Mar 2005

HIV virus removed from fathers sperm

27 babies in Japan have been born virus-free after the virus was removed from the the sperm of HIV-positive fathers.

7 Mar 2005

New compounds for the treatment of HIV/AIDS

Scientists from Tibotec Pharmaceuticals Ltd. presented data on several new compounds for the treatment of HIV/AIDS at the 12th Conference on Retroviruses and Opportunistic Infections (CROI), held February 22-25 in Boston, MA, USA.

27 Feb 2005

Scientists have replicated hepatitis C virus (HCV) in the laboratory

For the first time, scientists have replicated hepatitis C virus (HCV) in the laboratory. The ability to replicate HCV in cell culture will allow researchers to better study the life cycle and biology of this virus and to test potential antiviral compounds, which may lead to new therapies for the liver disease that results from infection with HCV.

22 Feb 2005

Better ways to heal and regenerate bones using microcomputed tomography imaging

Tissue engineers can choose from a wide range of living cells, biomaterials and proteins to repair a bone defect. But finding the optimum combination requires improved methods for tracking the healing process.

20 Feb 2005

Americans support appropriate use of reproductive genetic testing

A majority of Americans believes it is appropriate to use reproductive genetic testing to avoid having a child with a life-threatening disease, or to test embryos to see if they will be a good match to provide cells to help a sick sibling, a new report of the Genetics and Public Policy Center reveals.

20 Feb 2005

American Fertility Association alarmed by Judge's embryo ruling

The recent ruling in favor of a Chicago couple, who sued for wrongful death when their fertility clinic failed to preserve an embryo, raises great concerns for fertility patients across the United States.

13 Feb 2005

Researchers have discovered an ample source of stem cells in an uncharted part of the umbilical cord

The study, published in the February issue of Stem Cells, outlines how researchers discovered that the jelly-like connective tissue surrounding the blood vessels of the human umbilical cord, the so-called "Wharton's Jelly," is rich in mesenchymal progenitor cells – cells that generate bone, cartilage and other tissues – and can be harvested to generate an abundant supply in a short amount of time.

9 Feb 2005